Evidence map›Paper›PMID 40642555›Full record

ArticleHealth science reports2025

Women's Intention to Participate in Predictive Breast Cancer Genetic Testing: A Cross-Sectional Survey of in Iran.

Zahra Meshkani, Soheila Damiri, Najmeh Moradi, Mohadeseh Motamed-Jahromi, Ali Aboutorabi

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zahra MeshkaniNational Center for Health Insurance Research Tehran Tehran Province Iran.ORCID https://orcid.org/0000-0001-7994-2567
Soheila DamiriDepartment of Health Management, Policy and Economics, School of Public Health Tehran University of Medical Sciences Tehran Tehran Province Iran.ORCID https://orcid.org/0000-0002-4070-1894
Najmeh MoradiPopulation Health Sciences Institute, Newcastle University Newcastle upon Tyne England U.K.ORCID https://orcid.org/0000-0003-4172-4411
Mohadeseh Motamed-JahromiDepartment of Public Health, School of Health Fasa University of Medical Sciences Fasa Fars Province Iran.ORCID https://orcid.org/0000-0001-6025-4879
Ali AboutorabiHealth Management and Economics Research Center, Health Management Research Institute Iran University of Medical Sciences Tehran Tehran Province Iran.ORCID https://orcid.org/0000-0001-7840-0950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Breast cancer is the most prevalent cancer among women worldwide, with rising trends in prevalence, incidence, and mortality rates. Genetic testing for BRCA1 and BRCA2 variants plays a pivotal role in assessing risk and enabling early detection. Despite its importance, participation in breast cancer screening programs, including genetic testing, remains notably low in Iran. This study aimed to assess Iranian women's intention to undergo predictive genetic testing for breast cancer and identify associated factors to inform policymakers and intervention strategies. Methods: A cross-sectional online survey was conducted from July to August 2021 among 1041 Iranian women aged 30 and above. A validated questionnaire assessed demographics, psychological factors, personal and family cancer history, knowledge of breast cancer genetics, attitudes toward genetic testing, and testing intentions. Statistical analyses included Chi-square tests, Fisher's Exact Test, and logistic regression to identify predictors of testing intention. Results: Most participants (89.5%) expressed willingness to undergo genetic testing if it were free. Higher knowledge of breast cancer genetics (OR = 1.59, Conclusion: Despite limited knowledge, Iranian women demonstrated a strong interest in genetic testing for breast cancer. Educational interventions and policy measures to reduce financial barriers could enhance participation rates. Tailored programs addressing psychological concerns and improving genetic literacy are recommended to support informed decision-making and early detection efforts.

Indexed as

BRCA1/BRCA2 variantsbreast cancer genetic testinghealth behavior intentionIranian women's healthpredictive genetic screening

Identifiers

PMID40642555
PMCPMC12240870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.